ADICET BIO INC(NASDAQ:ACET) stock News

ACET Latest News, Press Relases and Analysis

All

Press Releases

a day ago - By: Adicet Bio, Inc.

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

11 days ago - By: Benzinga - Mentions: CLDX ALC BLRX TLPH ...

12 Health Care Stocks Moving In Tuesday's After-Market Session

19 days ago - By: Zacks Investment Research

Adicet Bio (ACET) Upgraded to Buy: Here's Why

20 days ago - By: Yahoo Finance - Mentions: MXCT

MaxCyte (MXCT) Signed a Strategic Platform License with Adicet Bio

23 days ago - By: The Motley Fool

Adicet Bio (ACET) Q2 Loss Widens 3%

23 days ago - By: Adicet Bio, Inc.

Adicet Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates

26 days ago - By: Adicet Bio, Inc.

Adicet Bio to Participate in a Fireside Chat at the 45th Annual Canaccord Genuity Growth Conference

a month ago - By: Adicet Bio, Inc.

Adicet Bio Announces First Systemic Sclerosis (SSc) Patient Dosed in Ongoing Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases

a month ago - By: Benzinga - Mentions: XYZ TELO EVO TNFA ...

Why Block Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket

3 months ago - By: Adicet Bio, Inc.

Adicet Bio to Participate in a Fireside Chat at the 2025 Jefferies Global Healthcare Conference

4 months ago - By: Zacks Investment Research

Adicet Bio (ACET) Upgraded to Buy: Here's What You Should Know

4 months ago - By: Adicet Bio, Inc.

Adicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates

4 months ago - By: Adicet Bio, Inc.

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

4 months ago - By: Adicet Bio, Inc.

Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference

4 months ago - By: Adicet Bio, Inc.

Adicet Bio Announces Oral Presentation Highlighting Preclinical ADI-270 Data at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting

5 months ago - By: Adicet Bio, Inc.

Adicet Bio Appoints Michael Grissinger to the Board of Directors

5 months ago - By: Adicet Bio, Inc.

Adicet Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

5 months ago - By: Adicet Bio, Inc.

Adicet Bio to Participate in 2025 Canaccord Genuity Horizons in Oncology Virtual Conference

6 months ago - By: Adicet Bio, Inc.

Adicet Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company Progress

6 months ago - By: Adicet Bio, Inc.

Adicet Announces Poster Presentations Highlighting ADI-270 Data at the Society for Immunotherapy of Cancer (SITC) 2025 Spring Scientific Meeting

6 months ago - By: Adicet Bio, Inc.

Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Systemic Sclerosis (SSc)

7 months ago - By: Adicet Bio, Inc.

Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Refractory Systemic Lupus Erythematosus (SLE) with Extrarenal Involvement

7 months ago - By: Adicet Bio, Inc.

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

7 months ago - By: Adicet Bio, Inc.

Adicet Bio to Participate in a Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference

8 months ago - By: Adicet Bio, Inc.

Adicet Bio Provides Corporate Update and Highlights Expected 2025 Milestones

8 months ago - By: Adicet Bio, Inc.

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

8 months ago - By: Adicet Bio, Inc.

Adicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma

9 months ago - By: Adicet Bio, Inc.